07.20.18
Top 25 Pharma and Biopharma Companies (Based on 2017 Pharma/Biopharma Sales, in $U.S. Millions)
01. Pfizer $52,546
02. Roche $42,219
03. Sanofi $41,991
04. Johnson & Johnson $36,256
05. Merck & Co. $35,390
06. Novartis $33,025
07. GlaxoSmithKline $30,270
08. AbbVie $28,216
09. Gilead $26,107
10. Eli Lilly & Co. $22,871
11. Amgen $22,849
12. AstraZeneca $22,465
13. Teva $22,385
14. Bristol-Myers Squibb $20,776
15. Bayer $20,180
16. Novo Nordisk $17,966
17. Takeda $16,663
18. Allergan $15,941
19. Boehringer Ingelheim $15,930
20. Shire $14,449
21. Celgene $13,003
22. Biogen $12,274
23. Astellas $12,238
24. Mylan $11,908
25. Otsuka $11,006
Contributors
Editor: Tim Wright
Managing Editor: Kristin Brooks
Associate Editor: Betsy Louda
*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year. Pharma/biopharmaceutical sales are the primary factor in the rankings, however results may include animal heath sales where applicable and other smaller division sales. Large medical device, diagnostics, and consumer care division revenues have been excluded from the rankings. Thank you for your time!
01. Pfizer $52,546
02. Roche $42,219
03. Sanofi $41,991
04. Johnson & Johnson $36,256
05. Merck & Co. $35,390
06. Novartis $33,025
07. GlaxoSmithKline $30,270
08. AbbVie $28,216
09. Gilead $26,107
10. Eli Lilly & Co. $22,871
11. Amgen $22,849
12. AstraZeneca $22,465
13. Teva $22,385
14. Bristol-Myers Squibb $20,776
15. Bayer $20,180
16. Novo Nordisk $17,966
17. Takeda $16,663
18. Allergan $15,941
19. Boehringer Ingelheim $15,930
20. Shire $14,449
21. Celgene $13,003
22. Biogen $12,274
23. Astellas $12,238
24. Mylan $11,908
25. Otsuka $11,006
Contributors
Editor: Tim Wright
Managing Editor: Kristin Brooks
Associate Editor: Betsy Louda
*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year. Pharma/biopharmaceutical sales are the primary factor in the rankings, however results may include animal heath sales where applicable and other smaller division sales. Large medical device, diagnostics, and consumer care division revenues have been excluded from the rankings. Thank you for your time!
